The catholic University of Korea, Seoul St. Mary`s hospital, 222 Banpo-daero

Seoul, Seocho-gu 06591

We've found

1 trials

at this facility

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Seoul,

Use our guide to learn which trials are right for you!